Alcohol Research in HIV: Relapse Prevention

Part of paid clinical trials in Baltimore, Maryland.

Sponsor
Johns Hopkins University
Study ID
NCT05163301
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Relapse Prevention Intervention — BEHAVIORAL
    2 session intervention to address relapse prevention among people with HIV who have an alcohol use disorder

Study Details

3-arm type 1 pilot implementation-efficacy trial for people with alcohol use disorders to examine the preliminary effectiveness and feasibility of an adapted 2-session, computerized and person delivered relapse prevention intervention.

Key Dates

Start date
Mar 27, 2023
Status verified
Feb 2026
Primary completion
Feb 25, 2027
Completion
May 31, 2027

Study Design

Enrollment
150 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Computer delivered RPI
    2 session computer delivered counseling to prevent relapse to hazardous drinking
  • Experimental: Person delivered RPI
    2 session counselor delivered counseling to prevent relapse to hazardous drinking
  • No Intervention: Treatment as Usual
    Counseling for alcohol use available in clinic as treatment as usual

Primary Outcome Measure

Change in time to relapse [ Time Frame: 6 and 12 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Johns Hopkins School of MedicineBaltimoreMaryland21287
Heidi Hutton
Heidi Hutton, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Baltimore, MD

By condition
Substance use disorderHIV
By specialty
Behavioral healthAddiction medicineInfectious disease
By research site
Johns Hopkins School of Medicine· Baltimore, MD

Related Studies